Novel cleavable cell-penetrating peptide-drug conjugates: synthesis and characterization
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Novel cleavable cell-penetrating peptide-drug conjugates: synthesis and characterization
Authors
Keywords
-
Journal
JOURNAL OF PEPTIDE SCIENCE
Volume 20, Issue 5, Pages 323-333
Publisher
Wiley
Online
2014-02-21
DOI
10.1002/psc.2617
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cell-penetrating peptides: classes, origin, and current landscape
- (2012) Francesca Milletti DRUG DISCOVERY TODAY
- Accumulation of arginine-rich cell-penetrating peptides in tumors and the potential for anticancer drug delivery in vivo
- (2012) Ikuhiko Nakase et al. JOURNAL OF CONTROLLED RELEASE
- Cell entry of cell penetrating peptides: tales of tails wagging dogs
- (2012) Arwyn T. Jones et al. JOURNAL OF CONTROLLED RELEASE
- Transient Focal Membrane Deformation Induced by Arginine-rich Peptides Leads to Their Direct Penetration into Cells
- (2012) Hisaaki Hirose et al. MOLECULAR THERAPY
- Doxorubicin-Tethered Responsive Gold Nanoparticles Facilitate Intracellular Drug Delivery for Overcoming Multidrug Resistance in Cancer Cells
- (2011) Feng Wang et al. ACS Nano
- Design, Synthesis and Characterization of a New Anionic Cell-Penetrating Peptide: SAP(E)
- (2011) Irene Martín et al. CHEMBIOCHEM
- Anthracycline-GnRH derivative bioconjugates with different linkages: Synthesis, in vitro drug release and cytostatic effect
- (2011) Pascal Schlage et al. JOURNAL OF CONTROLLED RELEASE
- Delay Time and Concentration Effects During Bioconjugation of Nanosecond Laser-Generated Nanoparticles in a Liquid Flow
- (2011) Csaba László Sajti et al. Journal of Physical Chemistry C
- Nanomedicine(s) under the Microscope
- (2011) Ruth Duncan et al. MOLECULAR PHARMACEUTICS
- Liposome-Encapsulated Doxorubicin Reverses Drug Resistance by Inhibiting P-Glycoprotein in Human Cancer Cells
- (2011) Chiara Riganti et al. MOLECULAR PHARMACEUTICS
- In vitro degradation and antitumor activity of oxime bond-linked daunorubicin–GnRH-III bioconjugates and DNA-binding properties of daunorubicin–amino acid metabolites
- (2010) Erika Orbán et al. AMINO ACIDS
- Happy birthday cell penetrating peptides: Already 20 years
- (2010) Robert Brasseur et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Structural polymorphism of non-covalent peptide-based delivery systems: Highway to cellular uptake
- (2010) Sébastien Deshayes et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Cell biology meets biophysics to unveil the different mechanisms of penetratin internalization in cells
- (2010) Isabel D. Alves et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Assessing the uptake kinetics and internalization mechanisms of cell-penetrating peptides using a quenched fluorescence assay
- (2009) Imre Mäger et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Development of an Oxime Bond Containing Daunorubicin-Gonadotropin-Releasing Hormone-III Conjugate as a Potential Anticancer Drug
- (2009) Ildikó Szabó et al. BIOCONJUGATE CHEMISTRY
- Hydrolytic Stability of Hydrazones and Oximes
- (2008) Jeet Kalia et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Effects of cell-penetrating peptides and pegylation on transfection efficiency of polyethylenimine in mouse lungs
- (2008) Juliane Nguyen et al. JOURNAL OF GENE MEDICINE
- Overcoming multidrug resistance of small-molecule therapeutics through conjugation with releasable octaarginine transporters
- (2008) E. A. Dubikovskaya et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Proline-rich, amphipathic cell-penetrating peptides
- (2007) Sílvia Pujals et al. ADVANCED DRUG DELIVERY REVIEWS
- Live-cell analysis of cell penetration ability and toxicity of oligo-arginines
- (2007) Gisela Tünnemann et al. JOURNAL OF PEPTIDE SCIENCE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started